Athena Countouriotis is a director of Biomarin Pharmaceutical Inc. - Registered Shares.
Person profile
Roles
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
IOVANCE BIOTHERAPEUTICS, INC.
5 Mar 24
4
BIOMARIN PHARMACEUTICAL INC
28 Dec 23
3
BIOMARIN PHARMACEUTICAL INC
28 Dec 23
4
IOVANCE BIOTHERAPEUTICS, INC.
8 Jun 23
4
Passage BIO, Inc.
26 May 23
4
Turning Point Therapeutics, Inc.
17 Aug 22
4
IOVANCE BIOTHERAPEUTICS, INC.
14 Jun 22
4
Passage BIO, Inc.
31 May 22
4
Turning Point Therapeutics, Inc.
11 Feb 22
4
IOVANCE BIOTHERAPEUTICS, INC.
1 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | IOVA Iovance Biotherapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 50,000 |
27 Dec 23 | BMRN Biomarin Pharmaceutical Inc. - Registered Shares | Common Stock | Grant | Acquire A | No | No | 0 | 2,180 | 0.00 | 2,180 |
6 Jun 23 | IOVA Iovance Biotherapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 51,955 | 0.00 | 51,955 |
25 May 23 | PASG Passage Bio | Director Stock Option Common Stock | Grant | Acquire A | No | No | 1 | 24,000 | 24.00 k | 24,000 |